Cyclerion Therapeutics, Inc. (CYCN) SEC filings
CYCN SEC filings moved a median of +1.62% by the close. CYCN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CYCN overview →
46 measured CYCN SEC filing events.
Where these CYCN SEC filings landedvs 43 measured CYCN SEC filing reactions
| Middle 50% of CYCN SEC filing reactions | -4.97% to +4.85% |
|---|---|
| Median reaction (to close) | +1.62% |
| Measured reactions | 43 |
Point-in-time · zero look-ahead
Half of the 43 CYCN SEC filing events with a measured close landed between -4.97% and +4.85%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Korsana Biosciences, For: Sep 08 | SEC filing · Form 8-K | — | — | |
| Form 8-K Cyclerion Therapeutics, For: Aug 26 | SEC filing · Form 8-K | +2.19% | -2.68% | |
| Form 8-K Cyclerion Therapeutics, For: Aug 25 | SEC filing · Form 8-K | -0.11% | +4.53% | |
| Form 10-Q Cyclerion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +1.43% | |
| Form EFFECT Cyclerion Therapeutics, | SEC filing · Form EFFECT | +3.95% | +2.64% | |
| Form S-4/A Cyclerion Therapeutics, | SEC filing · Form S-4 | +0.00% | -0.82% | |
| Form S-4/A Cyclerion Therapeutics, | SEC filing · Form S-4 | -0.78% | -0.39% | |
| Form S-4/A Cyclerion Therapeutics, | SEC filing · Form S-4 | +6.76% | +4.39% | |
| Form 10-Q Cyclerion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.46% | +1.62% | |
| Form 10-K/A Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.22% | +0.61% | |
| Form S-4 Cyclerion Therapeutics, | SEC filing · Form S-4 | +1.03% | +3.09% | |
| Form 8-K Cyclerion Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -1.01% | +24.49% | |
| Form 10-K Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | +6.16% | |
| Form 8-K Cyclerion Therapeutics, For: Feb 17 | SEC filing · Form 8-K | -1.60% | -0.80% | |
| Form 8-K Cyclerion Therapeutics, For: Jan 03 | SEC filing · Form 8-K | -5.76% | -10.14% | |
| Form 8-K Cyclerion Therapeutics, For: Dec 01 | SEC filing · Form 8-K | -0.01% | -1.92% | |
| Form 10-K/A Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.50% | — | |
| Form 10-Q Cyclerion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.50% | — | |
| Form 8-K Cyclerion Therapeutics, For: Sep 19 | SEC filing · Form 8-K | -4.79% | -8.45% | |
| Form 10-Q Cyclerion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.89% | -11.48% | |
| Form 8-K Cyclerion Therapeutics, For: Jun 16 | SEC filing · Form 8-K | — | -8.38% | |
| Form EFFECT Cyclerion Therapeutics, | SEC filing · Form EFFECT | +0.56% | +4.83% | |
| Form 8-K Cyclerion Therapeutics, For: May 07 | SEC filing · Form 8-K | -4.17% | -5.18% | |
| Form 10-Q Cyclerion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.48% | +12.83% | |
| Form S-3 Cyclerion Therapeutics, | SEC filing · Form S-3 | -1.48% | +12.83% | |
| Form DEF 14A Cyclerion Therapeutics, For: Jun 16 | SEC filing · Form DEF | +0.00% | +4.86% | |
| Form DEFA14A Cyclerion Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +4.86% | |
| Form 8-K Cyclerion Therapeutics, For: Mar 21 | SEC filing · Form 8-K | +0.00% | -8.54% | |
| Form 10-K Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.56% | -7.99% | |
| Form EFFECT Cyclerion Therapeutics, | SEC filing · Form EFFECT | +0.24% | -8.46% | |
| Form S-3 Cyclerion Therapeutics, | SEC filing · Form S-3 | -0.16% | +5.66% | |
| Form 8-K Cyclerion Therapeutics, For: Dec 13 | SEC filing · Form 8-K | -2.87% | -6.02% | |
| Form 10-Q Cyclerion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.70% | +45.76% | |
| Form 10-Q Cyclerion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | +4.07% | |
| Form 8-K Cyclerion Therapeutics, For: Aug 07 | SEC filing · Form 8-K | — | +4.07% | |
| Form 8-K Cyclerion Therapeutics, For: Jun 14 | SEC filing · Form 8-K | +0.00% | +1.75% | |
| Form 10-Q Cyclerion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.43% | |
| Form DEF 14A Cyclerion Therapeutics, For: Jun 14 | SEC filing · Form DEF | — | -7.52% | |
| Form DEFA14A Cyclerion Therapeutics, | SEC filing · Form DEFA14A | — | -7.52% | |
| Form 8-K Cyclerion Therapeutics, For: Apr 18 | SEC filing · Form 8-K | — | +0.29% | |
| Form 10-K Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | +3.70% | |
| Form 8-K Cyclerion Therapeutics, For: Dec 01 | SEC filing · Form 8-K | — | +9.23% | |
| Form 8-K Cyclerion Therapeutics, For: Nov 30 | SEC filing · Form 8-K | +3.01% | +6.72% | |
| Form 8-K Cyclerion Therapeutics, For: Nov 19 | SEC filing · Form 8-K | — | +0.00% | |
| Form 10-Q Cyclerion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -4.76% | |
| Form 8-K Cyclerion Therapeutics, For: Oct 17 | SEC filing · Form 8-K | — | +5.59% |
Keep exploring
More CYCN: earnings → · analyst actions → · CYCN overview →